{"entity":{"type":"insider","cik":"0001466061","url":"/insider/0001466061","json_url":"/insider/0001466061.json","name":"Harrell David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2010-09-27","last":"2014-04-28","span_basis":"filed_date"},"name_variants":[{"name":"Harrell David","source":"filing","n_filings":2,"first_seen":"2010-09-27","last_seen":"2014-04-28"}],"transactions":[{"id":6919363,"accession":"0001255294-14-000370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255294-14-000370","line_url":"/filing/0001255294-14-000370#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001466061","owner_name":"Harrell David","owner_display_name":"Harrell David","owner_url":"/insider/0001466061","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":552500.0,"shares_display":"552,500","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":884000.0,"total_display":"884,000.00","total_whole":"884,000","shares_owned_after":2705625.0,"shares_owned_after_display":"2,705,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-24","filed_date":"2014-04-28","scope":"insider"},{"id":7147280,"accession":"0001255294-10-000827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255294-10-000827","line_url":"/filing/0001255294-10-000827#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001466061","owner_name":"Harrell David","owner_display_name":"Harrell David","owner_url":"/insider/0001466061","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":3136250.0,"shares_owned_after_display":"3,136,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-22","filed_date":"2010-09-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001448431","name":"OptimizeRx Corp","url":"/issuer/0001448431","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":2,"first_seen":"2010-09-27","last_seen":"2014-04-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001466061","retrieved_at":"2026-08-24T19:27:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}